Literature DB >> 23665953

Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers.

Goknur Kalkan1, Nevin Karakus, Serbulent Yigit.   

Abstract

OBJECTIVES: Recurrent aphthous stomatitis (RAS) is a common ulcerative disease of the oral mucosa. Methylenetetrahydrofolate reductase (MTHFR) gene variants are associated with thrombophilia and vasculopathy that may result in oral ulceration. Oral ulcers are also the most common feature of Behcet's disease (BD). Association of MTHFR gene C677T mutation with BD has been reported in different populations. The aim of the present study was to investigate the possible association between MTHFR gene C677T mutation and RAS and evaluate if there was an association with clinical features in a relatively large cohort of Turkish patients.
MATERIALS AND METHODS: The study included 188 patients affected by RAS and 200 healthy controls. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR)-based restriction fragment length polymorphism (RFLP) assay for the MTHFR gene C677T mutation.
RESULTS: The genotype and allele frequencies of C677T mutation showed statistically significant differences between RAS patients and controls (p = 0.002 and p = 0.0004, respectively). After stratifying RAS patients according to clinical characteristics of oral ulcers, a significant association was observed between C677T mutation and number of oral ulcers of RAS patients (p = 0.006).
CONCLUSIONS: As a result, a high association between MTHFR gene C677T mutation and RAS was observed in the present study. Also number of oral ulcers was found to be associated with MTHFR C677T mutation in RAS patients. CLINICAL RELEVANCE: If our observation can be substantiated with further studies, evaluation for MTHFR mutations and perhaps folate supplementation may become necessary in selected patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23665953     DOI: 10.1007/s00784-013-0997-0

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  26 in total

1.  Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study.

Authors:  N Pipitone; L Boiardi; I Olivieri; F Cantini; F Salvi; R Malatesta; R La Corte; G Triolo; A Ferrante; D Filippini; G Paolazzi; P Sarzi-Puttini; G Restuccia; C Salvarani
Journal:  Clin Exp Rheumatol       Date:  2004       Impact factor: 4.473

Review 2.  Recurrent aphthous stomatitis.

Authors:  S R Porter; C Scully; A Pedersen
Journal:  Crit Rev Oral Biol Med       Date:  1998

Review 3.  Homocysteine, B vitamins, and coronary artery disease.

Authors:  N Seshadri; K Robinson
Journal:  Med Clin North Am       Date:  2000-01       Impact factor: 5.456

4.  Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

Authors:  Giuseppe Toffoli; Antonio Russo; Federico Innocenti; Giuseppe Corona; Salvatore Tumolo; Franca Sartor; Enrico Mini; Mauro Boiocchi
Journal:  Int J Cancer       Date:  2003-01-20       Impact factor: 7.396

5.  Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants.

Authors:  Gilbert M Wilcox; Anthony R Mattia
Journal:  J Clin Gastroenterol       Date:  2006-08       Impact factor: 3.062

Review 6.  DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Authors:  Olaf Stanger; Wolfgang Herrmann; Klaus Pietrzik; Brian Fowler; Jürgen Geisel; Jutta Dierkes; Martin Weger
Journal:  Clin Chem Lab Med       Date:  2003-11       Impact factor: 3.694

7.  Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A.

Authors:  S Ehrenforth; L Nemes; C Mannhalter; F R Rosendaal; S Koder; C Zoghlami-Rintelen; I Scharrer; I Pabinger
Journal:  J Thromb Haemost       Date:  2004-03       Impact factor: 5.824

8.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Authors:  S S Kang; J Zhou; P W Wong; J Kowalisyn; G Strokosch
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

9.  Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants.

Authors:  Simone Saibeni; Marco Cattaneo; Maurizio Vecchi; Maddalena Loredana Zighetti; Anna Lecchi; Rossana Lombardi; Gianmichele Meucci; Luisa Spina; Roberto de Franchis
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  1 in total

1.  A genome-wide association analysis: m6A-SNP related to the onset of oral ulcers.

Authors:  Zhuoxuan Wu; Weimin Lin; Quan Yuan; Mingyue Lyu
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.